Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1990 March; 83(3): 161.
PMCID: PMC1292561

Intracorporeal papaverine injection in androgen deprived men.


The intracorporeal injection of papaverine (ICP) is now a well recognized therapeutic option in the management of impotence. The current treatment of advanced prostatic carcinoma causes erectile failure. Although intracorporeal papaverine can induce erections in these men, libido is also reduced so that the role of ICP is limited to those men complying with the wishes of a highly motivated partner.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (205K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Virag R, Frydman D, Legman M, Virag H. Intracavernous injection of papaverine as a diagnostic and therapeutic method in erectile failure. Angiology. 1984 Feb;35(2):79–87. [PubMed]
  • Zorgniotti AW, Lefleur RS. Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence. J Urol. 1985 Jan;133(1):39–41. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press